文献速递心脑血管急症重症综合管理与镇静镇痛

创伤性脑损伤开颅术患者止血功能的动态变化与院内死亡率的关系

Dynamic Changes of Hemostasis in Patients with Traumatic Brain Injury Undergoing Craniotomy: Association with in-Hospital Mortality.
PubMed 文献 · Neurocrit Care · 2022-12-05
一句话结论创伤性脑损伤开颅术后早期低纤维蛋白原及纤溶异常与院内死亡风险升高相关,FIBTEM低凝值可助识别高危患者。

该研究对68例因孤立性创伤性脑损伤行开颅清除血肿和/或减压的患者,在入院后72小时内四个时间点(T0-T3)进行常规凝血检测和旋转血栓弹力图连续分析,主要终点为院内死亡率。总死亡率为22%,旋转血栓弹力图提示的低凝状态从T0的35.8%降至T3的15.9%。T0-T1早期低纤维蛋白原水平、纤溶亢进和纤溶关闭均与较高死亡率相关;FIBTEM凝血时间后10分钟血凝块振幅在T0≤13 mm和T1≤16.5 mm分别使死亡风险增加6.0倍(95%CI 1.54-23.13,p=0.010)和9.7倍(95%CI 2.06-45.36,p=0.004);FIBTEM最大血凝块强度在T0≤14.5 mm和T1≤18.5 mm分别使死亡风险增加6.3倍(95%CI 1.56-25.69,p=0.010)和9.1倍(95%CI 1.88-44.39,p=0.006);术后第1天(T1)纤维蛋白原<3 g/L与院内死亡率增加9.5倍相关(95%CI 1.72-52.98,p=0.01)。凝血活性增高与死亡率无关。作者认为,旋转血栓弹力图可为识别死亡风险增高的创伤性脑损伤患者提供重要信息,急性创伤性脑损伤神经外科患者可能需要维持较高纤维蛋白原水平。

要点

  • 创伤性脑损伤开颅术后T0-T1早期低纤维蛋白原、纤溶亢进和纤溶关闭与较高院内死亡率相关。
  • FIBTEM凝血时间后10分钟血凝块振幅T0≤13 mm(OR 6.0,95%CI 1.54-23.13,p=0.010)和T1≤16.5 mm(OR 9.7,95%CI 2.06-45.36,p=0.004)增加死亡风险。
  • FIBTEM最大血凝块强度T0≤14.5 mm(OR 6.3,95%CI 1.56-25.69,p=0.010)和T1≤18.5 mm(OR 9.1,95%CI 1.88-44.39,p=0.006)增加死亡风险。
  • 术后第1天(T1)纤维蛋白原<3 g/L与院内死亡率增加9.5倍相关(95%CI 1.72-52.98,p=0.01)。
  • 旋转血栓弹力图提示的低凝状态从T0的35.8%降至T3的15.9%,凝血活性增高与死亡率无关。

适用人群与场景

  • 因孤立性创伤性脑损伤行开颅清除血肿和/或脑减压的68例患者,入院后72小时内连续监测。

诊断标准与关键阈值

  • FIBTEM凝血时间后10分钟血凝块振幅:T0≤13 mm、T1≤16.5 mm为预测死亡的最佳截断值。
  • FIBTEM最大血凝块强度:T0≤14.5 mm、T1≤18.5 mm为预测死亡的最佳截断值。
  • 术后第1天(T1)纤维蛋白原<3 g/L。

处置流程与药物剂量

  • 作者认为,急性创伤性脑损伤神经外科患者可能需要维持较高纤维蛋白原水平。

红旗征与不能漏的情况

  • 早期(T0-T1)出现低纤维蛋白原水平、纤溶亢进或纤溶关闭提示死亡风险增高。
  • FIBTEM凝血时间后10分钟血凝块振幅T0≤13 mm或T1≤16.5 mm提示死亡风险增高。
  • FIBTEM最大血凝块强度T0≤14.5 mm或T1≤18.5 mm提示死亡风险增高。
  • 术后第1天纤维蛋白原<3 g/L提示院内死亡风险增加9.5倍(95%CI 1.72-52.98,p=0.01)。

研究设计与关键结果

  • 研究类型:对68例创伤性脑损伤开颅术后患者进行连续凝血检测和旋转血栓弹力图分析。
  • 总死亡率为22%。
  • 旋转血栓弹力图提示的低凝状态患病率从T0的35.8%降至T3的15.9%。
  • FIBTEM凝血时间后10分钟血凝块振幅T0≤13 mm增加死亡风险OR 6.0(95%CI 1.54-23.13,p=0.010),T1≤16.5 mm增加死亡风险OR 9.7(95%CI 2.06-45.36,p=0.004)。
  • FIBTEM最大血凝块强度T0≤14.5 mm增加死亡风险OR 6.3(95%CI 1.56-25.69,p=0.010),T1≤18.5 mm增加死亡风险OR 9.1(95%CI 1.88-44.39,p=0.006)。
  • 术后第1天(T1)纤维蛋白原<3 g/L与院内死亡率增加9.5倍相关(95%CI 1.72-52.98,p=0.01)。
  • 凝血活性增高与死亡率无关。

证据类型、等级与局限

  • 局限:原文未报告局限性。

对床旁实践的改变

  • 旋转血栓弹力图可为识别创伤性脑损伤开颅术后死亡风险增高的患者提供重要信息。
  • 作者认为,急性创伤性脑损伤神经外科患者可能需要维持较高纤维蛋白原水平。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Traumatic brain injury (TBI) induces complex systemic hemostatic alterations associated with secondary brain damage and death. We specifically investigated perioperative changes of hemostasis in patients with isolated TBI undergoing major neurosurgery and searched for their influence on outcome.

METHODS: Serial analysis (four time points, T0-T3) of conventional coagulation assay and rotational thromboelastometry data acquired during 72 h from admission of 68 patients who underwent craniotomy to remove hematoma and/or to decompress the brain was performed. The primary outcome was in-hospital mortality. Secondary outcomes were the prevalence of hypocoagulation and increased clotting activity, coagulation parameters between survivors and nonsurvivors, and cutoff values of coagulation parameters predictive of mortality.

RESULTS: Overall mortality was 22%. The prevalence of hypocoagulation according to rotational thromboelastometry decreased from 35.8% (T0) to 15.9% (T3). Lower fibrinogen levels, hyperfibrinolysis and fibrinolysis shutdown in the early period (T0-T1) following TBI were associated with higher mortality. Optimal cutoff values were identified: fibrin polymerization thromboelastometry (FIBTEM) clot amplitude at 10 min after clotting time ≤ 13 mm at T0 and FIBTEM clot amplitude at 10 min after clotting time ≤ 16.5 mm at T1 increased the odds of death by 6.0 (95% confidence interval [CI] 1.54-23.13, p = 0.010) and 9.7 (95% CI 2.06-45.36, p = 0.004), respectively. FIBTEM maximum clot firmness ≤ 14.5 mm at T0 and FIBTEM maximum clot firmness ≤ 18.5 mm at T1 increased the odds of death by 6.3 (95% CI 1.56-25.69, p = 0.010) and 9.1 (95% CI 1.88-44.39, p = 0.006). Fibrinogen < 3 g/L on postoperative day 1 (T1) was associated with a 9.5-fold increase of in-hospital mortality (95% CI 1.72-52.98, p = 0.01). Increased clotting activity was not associated with mortality.

CONCLUSIONS: Rotational thromboelastometry adds important information for identifying patients with TBI at increased risk of death. Early fibrinogen-related coagulation disorders are associated with mortality of patients with TBI undergoing major neurosurgical procedures. Maintenance of higher fibrinogen levels might be necessary for neurosurgical patients with acute TBI.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Rimaitis M, Cechanovičiūtė V, Bilskienė D, et al. Dynamic Changes of Hemostasis in Patients with Traumatic Brain Injury Undergoing Craniotomy: Association with in-Hospital Mortality. Neurocrit Care. 2022. PMID: 36471184. doi:10.1007/s12028-022-01639-4

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。